The dysregulation of DGAT2 and lipid metabolism enhances TLR3-mediated inflammation in keratinocytes and promotes CD8+ T cell activation, driving psoriasis development in keratinocyte-specific SPRY1-deficient mice. This evidence concerns the gene SPRY1 and psoriasis.